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Foot-and-mouth	 disease,	 also	 known	 as	 FMD,	 is	 caused	 by	 the	 aphthovirus	 Foot-and-mouth	
disease	virus	(FMDV),	which	is	a	highly	contagious	disease	of	cloven-hoofed	animals.	It	is	endemic	
in	Africa,	parts	of	South	America	and	southern	Asia.	 In	South	Africa,	 the	disease	 is	controlled	
essentially	 through	 prophylactic	 vaccination.	 Current	 vaccines	 on	 the	 market	 are	 chemically	
inactivated	virus	strains.	However,	these	are	not	considered	ideal	due	to	the	possibly	insufficient	
inactivation	which	 could	 fail	 to	 render	 the	virus	harmless.	Research	on	 recombinant	 vaccines	
which	obviate	the	need	for	high	biosafety	requirements	for	vaccine	preparation	has	shown	that	










to	 circumvent	 this,	 and	 encourage	 more	 efficient	 production	 of	 the	 capsid	 proteins	 and	















using	oP1-2A.	The	 stability	of	 the	plant-produced	VLPs	was	assessed	by	 counting	numbers	of	
VLPs,	when	it	was	seen	that	expression	of	mP1-2A-3C	compared	to	oP1-2A	produced	an	average	























































































































































































































of	 FMDV	and	 can	harbour	 the	 virus	 for	2	 to	3	 years	 (Brooksby,	 1982).	 FMDV	 is	 known	 to	be	





and	 the	Middle	 East	 are	 still	 affected	by	 incidences.	 FMDV	 is	 on	 the	Office	 International	 des	
Epizooties	(OIE)	list	of	notifiable	animal	diseases,	and	they	are	authorized	to	recognize	countries	
and	 geographical	 zones	 according	 to	 their	 FMDV-free	 status	 for	 trade	 purposes.	 These	 are	
















1996).	 Vaccinated	 animals	 are	 also	 prone	 to	 the	 acute	 disease	 if	 persistently	 exposed	 to	 the	
infectious	virus	leading	to	an	active	replication	phase	for	up	to	72	hours	post-infection	(Pega	et	








RNA	 using	 reverse-	 transcription	 PCR	 (RT-PCR).	 The	 presence	 of	 FMDV	 infection	 using	 this	
method	 should	 further	 be	 confirmed	 via	 inoculation	 of	 samples	 into	 sensitive	 cell	 cultures.	
Positive	 testing	 for	 infection	 should	 include	 implementing	 a	 strategy	 to	 control	 the	 outbreak	
within	a	feasible	time-frame	(Callens	and	De	Clercq,	1997;	Rweyemamu	et	al.,	2008).	There	are	




Prophylactic	 FMD	 vaccines	 currently	 in	 use,	 help	 to	 differentiate	 between	 infected	 and	
vaccinated	 animals,	 as	 these	 are	 all	 inactivated	 virion	 preparations	 made	 using	 chemically-


























of	 the	disease	often	 impacts	heavily	on	 the	economy,	with	 the	 slowing	down	of	 the	 trade	of	
livestock	and	meat	products.	The	OIE	is	an	international	committee	which	assigns	countries	the	
FMD-free	 status	 based	 on	 certain	 stringent	 rules.	 The	 FMD	 committee	 and	 other	 Epizootics	
Commission	meet	twice	a	year,	and	after	evaluation	of	certain	submitted	documentation	and	
other	 information	 collected	 from	 a	 delegate,	 it	 is	 then	 proposed	 that	 a	member	 country	 be	
recognised	as	free	of	the	disease.	The	OIE	member	countries	are	also	given	a	60	day	consultation	
period	(Bruckner	et	al.,	2002;	Vosloo	et	al.,	2002).	
Western	 European	 countries	 have	 implemented	 vaccination	 programs	 which	 resulted	 in	 the	
cessation	of	disease	outbreaks	after	the	1990s.	South	America	followed	in	those	footsteps,	and	














































has	not	yet	been	established.	Located	 further	3’	of	 these	pseudoknots	 is	a	 short	hairpin-loop	
structure	which	has	been	identified	as	a	cis-acting	replicative	element	(cre)	that	is	vital	for	RNA	
genome	replication	(Mason	et	al.,	2002).	A	highly	conserved	450	base	stem-loop	structure,	the	
internal	 ribosome	 entry	 site	 (IRES),	 is	 located	 between	 the	 cre	 and	 the	 ORF	 (Belsham	 and	
Brangwyn,	1990).	This	is	the	entry	site	for	the	ribosomes	to	enter	the	genome	during	translation,	
which	is	further	discussed	in	the	infectious	cycle	section	1.4	(Jang	et	al.,	1988).	In	juxtaposition	
to	 the	 5’-UTR,	 the	 L-protein	 ORF,	 also	 known	 as	 the	 ‘Leader’	 protein,	 encodes	 a	 papain-like	
protease	which	is	autocatalytically	cleaved	at	its	C-terminus.	It	is	referred	to	as	L	and	not	P0	to	
avoid	confusion	with	 the	naming	of	 the	coat	protein	VP0.	The	protease	plays	a	major	 role	 in	





























a	 sedimentation	 rate	 of	 140	 Svedberg	units	 (S).	 The	different	 intermediates	 of	 assembly	 and	
























genome	 penetration	 from	 the	 endosomes	 (Caridi	 et	 al.,	 2015).	 Disassembly	 of	 the	 virion	 is	
promoted	by	the	protonation	of	the	histidines	(His)	residues	at	the	interpentameric	interfaces	
(Martín-Acebes	et	al.,	2010).	The	poor	thermostability	of	the	FMDV	particles	is	also	correlated	to	




















FMDV	 with	 the	 host	 cell	 start	 at	 the	 surface	 membranes,	 with	 entry	 via	 receptor-mediated	
(integrin	 and	 heparan	 sulfate	 [HS]	 receptors)	 endocytosis	 (Figure	 1.4,	 step	 1).	 Though	many	
receptors	are	involved,	Robertson	and	his	co-workers	demonstrated	that	G-H	loops	(Figure	1.3A)	
	 11	










Following	 adsorption	 and	 internalization	 of	 the	 viral	 genome	 is	 the	 onset	 of	 translation.	 The	
genome-linked	 protein	 VP
g	
is	 first	 cleaved	 off	 by	 cellular	 enzymes	 before	 the	 translation	 of	
incoming	 RNA,	 and	 then	 associates	 with	 ribosomes	 in	 the	 host	 cell	 and	 participates	 in	 a	
translation	initiation	complex	(Figure	1.4,	step	3)	(Ambros	and	Baltimore,	1980;	Ambros	et	al.,	
1978).	Protein	synthesis	begins	from	the	IRES	located	upstream	of	the	ORF.	The	poly(C)	found	in	























5’-ends	 of	 both	 the	 plus	 and	minus-strand	 are	 attached	 to	 VPgs,	 and	 a	 small	 protein-linked	
dinucleotide	UpU	 acts	 as	 a	 primer	 for	 the	 RNA	polymerase.	 In	 this	way,	 the	 polymerase	 can	
distinguish	between	viral	RNA	and	cellular	RNA	in	order	to	proceed	with	translation	of	the	cellular	
RNA	 to	produce	 the	plus-strand	 viral	 RNA.	 The	nascent	 strands	elongate	 (Figure	1.4,	 step	5),	
resulting	in	double-stranded	molecules	-	namely,	the	replicative	form	(Osorio	et	al.)	(Agol	et	al.,	
1999)	-	after	which	a	new	plus-strand	can	now	be	synthesized.	For	the	process	to	occur,	the	RF	
has	 to	 unwind.	 FMDV	 2C	 has	 helicase	 properties	 which	 are	 suggested	 to	 participate	 in	 the	
































Currently,	 inactivated	 whole-virus	 vaccines	 are	 commercially	 available	 to	 address	 FMDV	
outbreaks.	The	origins	of	this	vaccine	date	back	to	the	early	nineteen	forties,	in	Germany,	where	
Waldmann	 and	 his	 coworkers	 discovered	 that	 virus	 isolated	 from	 cattle	 could	 be	 inactivated	
using	 formaldehyde.	This	 inactivated	form	when	 later	 injected	 in	cattle	would	result	 in	FMDV	
immunity	 in	 the	 animals.	 Eventually,	 it	 was	 shown	 that	 the	 inactivated	 virus	 adsorbed	 onto	









and	 incubated	with	 a	particular	 strain	of	 virus	 (Barteling	 and	Vreeswijk,	 1991;	 Frenkel,	 1951;	
Lombard	et	al.,	2007).	Countries	such	as	the	Netherlands	and	France	quickly	adopted	the	FMDV	










inactivated	 by	 binary	 ethyleneimine.	 However,	 there	 are	 disadvantages	 to	 using	 inactivated	
vaccines	 which	 include	 the	 high	 cost	 of	 cell	 culture,	 insufficient	 inactivation,	 and	 the	 risk	 of	
release	of	the	wild-type	virulent	virus	from	production	facilities.	
1.5.2. Live	attenuated	vaccines	
In	 the	 early	 nineteen	 sixties,	 researchers	 in	 countries	 such	 as	 Britain,	 France,	 Germany	 and	
Uruguay	became	heavily	engaged	in	the	development	of	an	attenuated	FMD	vaccine	(Sutmoller	




The	 common	method	 for	 production	 of	 attenuated	 vaccines	 at	 that	 time	 involved	 the	 serial	
passage	of	 the	 virus	 in	 foreign	hosts	 such	as	baby	 rabbits	 (Cunha	et	 al.,	 1964),	 embryonated	
chicken	eggs	or	one-day	old	chicks	(Gillepsie,	1954).	The	‘adapted’	virus	would	then	be	tested	in	
cattle	 and	 further	 tested	 on	 a	 larger	 scale	 when	 pathogenicity	 was	 reduced	 and	 the	 cattle	
survived	after	viral	challenge	(Polacino	et	al.,	1985).		Sutmoller	and	his	researchers	at	that	time,	
after	 vaccination	 of	 some	 5000	 cattle,	 noticed	 that	 vaccinated	 animals	 would	 often	 remain	
asymptomatic;	however,	there	was	a	high	mortality	of	calves	which	were	vaccinated	with	rabbit-








not	 respond	 favourably	 to	 the	vaccine	doses.	Furthermore,	 live	attenuated	vaccine	had	to	be	










et	 al.	 (1986)	 showed	 that	 cattle	were	 protected	when	 they	were	 immunized	with	 a	 peptide	
encoding	the	G-H	loop	and	the	C-terminal	(residues	200-213)	of	VP1.	Francis	and	his	group	in	
1990	 demonstrated	 that	 synthetic	 peptides	 elicited	 neutralizing	 antibodies	 to	 all	 the	 seven	
known	serotypes	of	FMDV	 in	guinea-pigs	 (Francis	et	al.,	1990)	while	Pfaff	and	coworkers	also	









FMDV-neutralizing	 antibodies	 as	 well	 as	 activating	 an	 FMDV-specific	 T	 cell	 response	 in	 pigs	
(Cubillos	 et	 al.,	 2008).	 There	 are	many	 drawbacks	 associated	with	 this	 strategy	 to	 provide	 a	
suitable	 vaccine	 to	 combat	 FMDV,	 such	 as	 the	 limited	 number	 of	 antigenic	 sites	 which	 are	







Recombinant	 proteins	 of	 FMDV	 have	 also	 been	 extensively	 studied,	 and	 have	 also	 been	
investigated	as	candidate	FMDV	vaccines.	An	effective	immune	response	is	achieved	either	by	
having	a	series	of	epitopes	on	a	single	polypeptide	chain	or	by	having	B	and	T	cell	polyepitope	
proteins	 (McCullough	et	al.,	 1992).	Bae	et	al.,	 in	2009,	used	 the	3D	 sequence	which	 is	highly	
conserved	and	immunogenic,	along	with	VP1	which	has	both	B	and	T	cell	epitopes.	The	genes	
were	 codon-optimised	 and	 cloned	 into	 mammalian	 cell	 expression	 vectors.	 Downstream	
experiments	demonstrated	that	BALB/c	mice	co-immunized	with	the	3D	and	VP1	DNA	or	proteins	
showed	 humoral	 and	 cellular	 immune	 responses	 (Bae	 et	 al.,	 2009).	 Moreover,	 in	 2011,	
Andrianova	et	al.	produced	a	recombinant	protein	comprising	of	viral	epitopes.	They	used	the	B-
cell	 epitopes	 of	 proteins	 VP1	 and	 VP4	 and	 the	 T-cell	 epitopes	 of	 proteins	 2C	 and	 3D.	 The	















boosts.	 The	 sera	 of	 the	 animals	which	were	 inoculated	with	 the	wild-type	 form	 showed	 the	
presence	of	FMDV-specific	neutralizing	antibodies	(Mayr	et	al.,	2001)	and	all	the	animals	from	
the	 same	 group	were	 protected	 from	 clinical	 disease,	 compared	 to	 the	 naïve	 animals	which	




















Moreover,	 the	 potential	 of	 FMDV	 DNA	 vaccines	 could	 be	 significantly	 improved	 by	 the	 co-


















of	 empty	 capsids	 to	 be	 used	 as	 FMDV	 vaccines.	 Biochemical	 assays	 supported	 the	 fact	 that	
portions	of	 the	processed	P1	fragments	assembled	 into	capsid	 intermediate	complexes	which	















3C	 sequences.	 The	 experiment	 was	 monitored	 via	 the	 production	 of	 VP1	 protein	 and	
	 19	
implementation	 of	 3C	 mutants	 generated	 the	 most	 VP1	 as	 confirmed	 by	 western	 blotting.	






































Plants	 could	 help	 circumvent	 many	 of	 the	 negative	 issues	 discussed	 above;	 namely,	 the	
requirement	for	biocontainment	facilities,	the	limited	time-frame	for	the	efficient	production	of	





and	 specifically	 in	 transgenic	 tobacco	 and	 in	 potatoes	 (Mason	 et	 al.,	 1996).	 Production	 of	
recombinant	vaccines	 in	transgenic	plants	became	the	new	method	for	circumventing	several	
issues	posed	by	 expression	 systems	 as	 previously	 stated.	 This	 type	of	 genetic	 transformation	
refers	to	the	insertion	of	the	gene	of	interest	into	the	plant	genome,	so	that	these	plants	act	as	







the	 mice	 developed	 a	 strong	 immune	 response	 to	 FMD.	 The	 immunized	 mice	 were	 further	















made	 use	 of	 transgenic	 alfalfa	 plants	 to	 express	 only	 the	 structural	 protein	 VP1.	 After	
confirmation	of	the	presence	of	the	transgenes	in	the	said	plants,	mice	were	either	immunized	
via	 needle	 or	 fed	 with	 leaf	 extracts.	 In	 both	 cases,	 they	 developed	 a	 virus-specific	 immune	
response	as	speculated.	Furthermore,	the	mice	were	protected	from	challenge	which	brought	to	





from	 the	 transgenic	 plants	 was	 relatively	 low	 and	 would	 thus	 inevitably	 require	 further	
purification	and	concentration	processes.	This	could	lead	to	high	costs	of	production.	Moreover,	













Recently,	 researchers	 have	 produced	 a	 number	 of	 	 bovine	 candidate	 vaccines	 transiently	 in	





























virus	 (Knight-Jones	 et	 al.,	 2016;	 Lombard	 et	 al.,	 2007).	 The	 vaccines	 are	 produced	 in	 large	
bioreactors	 which	 require	 high	 biocontainment	 facilities.	 However,	 recent	 research	 on	
recombinant	vaccines,	which	help	to	circumvent	the	need	for	high	biosafety	requirements,	have	








However,	 these	are	produced	 in	mammalian	or	 insect	cells,	which	still	 represent	a	biosafety	
hazard	from	possible	contamination	with	agents	which	could	infect	target	animals.	Plants	such	
as	N.		benthamiana,	on	the	other	hand,	provide	a	safer	host	for	the	production	of	recombinant	
proteins	 and	 VLPs,	 as	 their	 use	 considerably	 reduces	 the	 risk	 of	 gene	 leakage	 into	 the	
environment	 because	 of	 the	 lack	 of	 cross-infecting	 disease	 agents	 (Shah	 et	 al.,	 2013).	 Plant	
production	 platforms	 can	 further	 be	 classified	 into	 either	 transgenic	 or	 transient	 expression	
systems.	While	the	transgenic	method	deals	with	the	insertion	of	the	gene	of	interest	into	the	
plant	 genome,	 for	 the	 transient	 system	 the	 gene	 is	 not	 integrated	 into	 the	 genome	 and	
expression	is	accomplished	by	Agrobacterium-mediated	infiltration.	The	transient	system	is	a	
much	quicker	method	to	produce	recombinant	protein	(days	vs.	months)	as	it	does	not	rely	on	








They	 observed	 that	 transient	 expression	 with	 the	 pEAQ-HT	 vector	 resulted	 in	 the	 highest	
expression	levels	of	GFP,	which	the	authors	postulated	was	a	result	of	a	P19	expression	cassette	
being	 integrated	 into	 the	 T-DNA	 of	 the	 vector.	 P19	 sometimes	 play	 an	 important	 role	 for	
expression	 of	 recombinant	 proteins	 in	 plant	 expression	 systems	 as	 it	 is	 known	 that	
posttranscriptional	gene	silencing	(PTGS)	has	a	negative	impact	on	expression	of	proteins.	PTGS	












my	 study	 consisted	 of	 the	 comparison	 of	 transiently	 expressed	 N.	 benthamiana	
codon-optimised	 FMDV	 Type	 A	 P1-2A-3C	 constructs.	 Expression	 of	 the	 capsid	
precursor	 was	 also	 monitored	 in	 the	 absence	 of	 the	 3C-protease.	 FMDV	 Type	 A	
constructs	were	used	for	expression	as	a	proof	of	concept,	and	similarly,	FMDV	Type	
SAT	1,	2	and	3	P1-2A	can	also	be	expressed	for	future	studies.	
(ii) Furthermore,	 FMDV	 VLPs	 are	 known	 to	 be	 acid-labile	 which	 are	 also	 prone	 to	
disassembly	at	extreme	temperatures.	Unlike	enteroviruses	which	release	their	RNA	
by	 receptor-mediated	 uncoating	 (Porta	 et	 al.,	 2013a),	 the	 FMDV	 capsids	 must	
dissociate	 to	 release	 their	 genome	which	partially	 explains	 the	weak	electrostatic	
interactions	at	low	pH	and	at	elevated	temperatures.		Vaccines	which	are	made	up	
of	 these	 empty	 capsids	 should	 therefore	 be	 able	 to	withstand	 such	 conditions	 to	
promote	a	longer	shelf-life.	Towards	the	long-term	aim	of	developing	a	vaccine	which	
will	 alleviate	 the	 constraints	 posed	 by	 the	 current	methods	 of	 production	 and	 to	
promote	shelf-life	of	such	a	vaccine,	the	second	objective	was	to	transiently	express	
derived-FMDV	 acid	 and	 heat-resistant	mutants’	 proteins	 to	 produce	 highly	 stable	
VLPs,	in	the	absence	of	the	3C-protease.	









FMDV	 vaccines	 currently	 available	 on	 the	market	 consist	 of	 purified,	 inactivated	whole	 virus	













and	Wigdorovitz,	 2005).	 In	most	 cases,	 the	VLPs	have	been	 shown	 to	be	 immunogenic	when	
injected	in	animals	(Porta	et	al.,	2013a;	Rodriguez	and	Grubman,	2009).	
Nevertheless,	these	above-mentioned	systems	relied	on	the	expression	of	a	mutated	form	of	the	















structures	 (Malys	 and	 McCarthy,	 2011;	 Malys	 and	 Nivinskas,	 2009).	 The	 TripleT	 Biosciences	












transitions	 together	 with	 a	 reduction	 of	 stem	 size	 would	 result	 in	 an	 increase	 in	 translation	
efficiency.	 Considering	 all	 these	 analyses,	 an	 algorithm	 was	 thus	 developed	 and	 tested	
successfully	in	plants,	showing	an	increase	in	protein	production	of	the	same	three	genes	tested	
before	(Westerhof,	2016).			
One	 of	 the	 ways	 of	 increasing	 protein	 and	 therefore	 VLP	 production	 would	 be	 to	 increase	
translation	efficiency	of	 the	RNA	of	 interest.	 Therefore,	 one	of	 the	 aims	of	 this	 study	was	 to	
optimise	the	expression	of	FMDV	VLPs	in	N.	benthamiana	by	firstly,	investigating	the	translation	
efficiency	of	differently	codon-optimised	P1-2A-3C	constructs	 in	order	to	try	and	increase	VLP	
yields.	 	We	 tested	 the	 expression	 of	 P1-2A-3C	which	was	 codon-optimised	 using	 the	 TripleT	
biosciences	algorithm,	and	compared	this	with	the	original	P1-2A-3C	construct	previously	used	
	 28	
























Figure	 2.1:	 The	 RNA	 structures	 of	 oP1-2A-3C	 and	 mP1-2A-3C	 as	 generated	 by	 CLC	 Workbench	 6.0	 (QIAGEN	
Bioinformatics).	(A)	oP1-2A-3C,	DG=	-873.0	kcal/mol.	(B)	mP1-2A-3C,	DG=	-955.1	kcal/mol.	
	
Codon	 optimised	 genes	 were	 received	 from	 GenScript	 (USA)	 in	 the	 pUC57	 vector.	 These	
constructs	were	used	as	template	DNA	for	Polymerase	Chain	Reaction	(PCR)	amplification	of	the	
mP1-2A-3C,	mP1-2A	and	oP1-2A	genes.	
















AgeI	 ATACCGGTCCCATGGGTGCT	 20	 62.1	
mP1-2A-3C	
reverse	
XhoI	 ATCTCGAGTTACATGACGTGGACG	 24	 62.2	
mP1-2A	forward	 AgeI	 ATACCGGTCCCATGGGTGCT	 20	 62.1	
mP1-2A	reverse	 XhoI	 ATCTCGAGTCAACCAGGGTTAGAC	 24	 62.1	
oP1-2A	forward	 AgeI	 ATACCGGTATGGGAGCAGGTC	 21	 56.2	













Biolabs).	 Alternatively,	 the	 KAPA	 HiFi	 HotStart	 ReadyMix	 PCR	 Kit	 was	 also	 used	 for	 gene	
	 30	
amplification	and	consisted	of	template	DNA,	1x	KAPA	HiFi	HotStart	ReadyMix,	0.3	µM	forward	
primer,	 0.3	 µM	 reverse	 primer.	 Control	 reactions	 contained	 all	 reagents	 except	 the	 DNA	


























(Thermo	 Scientific).	 Digests	 were	 carried	 out	 for	 2	 hours	 at	 37
o





































Primer	 Oligonucleotide	sequence	(5’	to	3’)	 Length	(bp)	 Tm	(
o
C)	
pEAQ-HT	forward	 TTCTTCTTCTTGCTGATTGG	 20	 46.3	





















medium,	with	 the	 respective	 antibiotics	 and	 incubated	 at	 27
o
C	 overnight	with	 agitation.	 The	
resuspension	 medium	 used	 to	 dilute	 the	 cultures	 to	 the	 desired	 OD
600
	 contained	 10	 mM	
ethanesulfonic	acid	(MES),	20	µM	acetosyringone,	and	appropriate	antibiotics.	
Cell	 suspensions	 of	 OD
600	




































antibodies	 used	 to	 detect	 the	 capsid	 proteins	which	were	 either	 polyclonal	 anti-serum	 from	
guinea-pigs	having	been	infected	with	FMDV,	serotype	A1	(diluted	1:	100	in	blocking	buffer)	or	
mouse	anti-His	antibody	(Sigma-Aldrich)	(diluted	1:	2000).	Membranes	were	washed	four	times	





1:	 5000	 alkaline	 phosphatase	 conjugated	 anti-	 rabbit	 antibody	 (Sigma-Aldrich)	 was	 used	 as	
secondary	 antibody	 if	 the	 polyclonal	 anti-P1-2A	 rabbit	 sera	 was	 used.	 The	 incubation	 was	
followed	by	four	washes	for	15	min	with	1x	PBS-T	and	the	proteins	were	detected	with	5-bromo-









Fifteen	 percent	 SDS-PAGE	 gels	 were	 stained	 using	 Coomassie	 Brilliant	 Blue	 R250	 stain	 (1%	
































isopropyl	b-D-1-thiagalactopyranoside	 IPTG	 (0.6	mM)	when	 the	optical	density	 reached	a	 cell	
density	 of	 OD
600	
of	 0.6.	 P1-2A	 was	 partially	 purified	 using	 the	 BugBuster
®	
Protein	 Extraction	
Reagent	 (Novagen)	 according	 to	 the	 protocol	 provided	 for	 inclusion	 body	 purification	 with	
additional	washes	using	1x	PBS	to	solubilize	the	protein.		
2.2.14.	Polyclonal	P1-2A	antibody	production	in	rabbits	
Female	 New	 Zealand	 white	 rabbits	 sourced	 from	 South	 African	 Veterinary	 Products	 (SAVP,	
Johannesburg)	were	housed	under	Biosafety	Level	2	(BSL	2)	conditions	in	the	Research	Animal	




in	section	2.2.12,	 followed	by	four	 inoculation	boosts,	within	a	two-week	 interval	 for	the	first	









respectively)	 and	 modified	 at	 the	 5’	 and	 3’	 termini	 for	 cloning	 into	 pEAQ-HT.	 PCR	 controls	















Ligated	 constructs	 pEAQ-HT-mP1-2A-3C,	 pEAQ-HT-mP1-2A	 and	 pEAQ-HT-oP1-2A	 were	
transformed	into	E.	coli	and	the	recombinant	clones	were	digested	to	confirm	the	presence	of	
the	respective	inserts.	Figure	2.3	shows	some	of	the	putative	recombinant	clones	which	had	the	






Figure	 2.3:	 Restriction	 enzyme	 digestion	 of	 pEAQ-HT-mP1-2A-3C,	 pEAQ-HT-mP1-2A	 and	 pEAQ-HT-oP1-2A.	 The	


























































pelleted	 through	 a	 30%	 sucrose	 cushion	 to	 remove	 as	 many	 contaminants	 as	 possible.	
Subsequently,	 the	 pellet	 was	 resuspended	 in	 NTE	 buffer	 and	 matured	 in	 the	 presence	 of	
	
	 38	
Benzonase,	 to	 improve	 maturation	 in	 the	 absence	 of	 nucleic	 acids,	 after	 which	 it	 was	 then	
centrifuged	through	a	linear	gradient	to	purify	VLPs.	All	the	fractions	were	first	analysed	on	dot-
blots	(data	not	shown)	and	selected	fractions	were	consequently	analysed	by	western	blot.	
The	western	 blot	 analysis	 of	 purified	 pEAQ-HT-mP1-2A-3C	 shows	 the	 presence	 of	 the	 capsid	
proteins	VP0	(~34	kDa)	with	VP1	and	VP3	being	approximately	the	same	size	(~27	kDa)	in	fractions	
8	and	9,	though	the	yields	were	low	as	evidenced	by	the	observation	of	faint	bands	(Figure	2.5B),	









Transmission	 electron	 micrograph	 of	 selected	 purified	 fractions	 of	 mP1-2A-3C	 revealed	 the	
presence	of	one	VLP	per	field	of	view,	and	the	presence	of	VLPs	of	variable	sizes	(30	to	35	nm)	

















As	 seen	 from	 the	 results	 in	 section	 2.3.3	 above,	 expression	 of	 oP1-2A	 resulted	 in	 the	 best	
expression	from	the	large-scale	infiltration,	and	therefore	this	particular	construct	was	chosen	
for	the	maturation	trial	experiments	using	the	optimum	conditions	determined	in	2.3.3.		
VLPs	 are	 formed	 from	 capsid	 proteins	which	 self-assemble	 to	 form	 the	 particle.	Usually,	 this	
formation	 is	 dependent	 on	 many	 external	 factors	 such	 as	 temperature	 and	 pH	 of	 the	
environment.	 Grubman	 and	 Baxt	 (2004)	 described	 how	 FMDV	 VLPs	 are	 stable	 at	 pH	 above	
neutrality,	and	we	thus	investigated	the	effect	that	different	maturation	times	would	have	on	
capsid	 assembly	while	maintaining	 a	 pH	 of	 8.0.	Maturation	was	 carried	 out	 on	 resuspended	
pellets	in	the	presence	of	Benzonase	at	room	temperature	for	30,	45	and	60	min	before	loading	
the	matured	material	 onto	 continuous	 gradients.	 Figure	 2.7	 shows	 the	western	 blot	 and	 EM	
analyses	of	purified	fractions	collected	from	the	continuous	gradients.	Figure	2.7A	(i)	shows	the	
presence	 of	 the	 different	 VPs	 in	 purified	 fractions	 2	 to	 8	 after	 30	 minutes	 of	 maturation.	
Concentric	VLPs	measuring	~30	nm	were	visualized	under	TEM	(Figure	2.7A	(ii)).	Similar	results	



















inclusion	 bodies	 allowed	 the	 visualization	 of	 a	 band	 of	 ~83	 kDa	 representing	 P1-2A	 on	 both	
western	blot	and	on	Coomassie-stained	gel	after	12	washes	in	1x	PBS	(Figure	2.8).	T0	represents	


















































South	Africa	 to	 combat	 FMD	consists	of	 inactivated	whole	 virus	preparations	which	 can	be	a	
biosafety	hazard	both	due	to	the	risk	of	 release	of	 the	virus	and	 incomplete	 inactivation.	The	
expression	 of	 FMDV	 VLPs	 using	 recombinant	 technology	 constitutes	 a	 feasible	 strategy	 to	






P1-2A-3C	 and	 P1-2A	 constructs	 which	 were	 plant	 (N.	 benthamiana)	 codon-optimised	 to	
determine	whether	VLP	yields	could	be	 increased.	Proteolytic	processing	of	P1-2A	by	 the	3C-
protease	is	important	in	the	production	of	proteins	VP0,	VP1	and	VP3,	which	self-assemble	to	
form	 the	 viral	 capsid	 (Grubman	 and	 Baxt,	 2004;	 Li	 et	 al.,	 2012).	 In	 this	 study,	 oP1-2A	 was	
expressed	in	the	absence	of	the	3C-protease	as	our	group	has	shown	previously	that	proteolytic	
cleaving	into	VP0,	VP1	and	VP3	can	occur	in	plants	in	the	absence	of	3C,	and	it	was	further	used	














to	 harbor	 cysteine	 proteases	which	might	 be	 involved	 in	many	 processes	 such	 as	 proprotein	
processing,	 programmed	 cell-death	 and	 especially	 in	 protein	 turnover.	 While	 the	 tobacco	













































































contributes	 to	viral	dissemination	and	 infection	 (Caridi	et	al.,	 2015).	However,	aphthoviruses,	
which	are	not	acid	resistant,	lose	their	infectivity	and	immunogenicity	due	to	their	disassembly	
in	 culture	 environments	 below	 a	 neutral	 pH	 (Liang	 et	 al.,	 2014).	 In	 the	 case	 of	 FMDV,	 this	
phenomenon	results	in	the	disintegration	of	its	capsid	into	12S	pentameric	subunits	containing	
five	copies	each	of	VP1	and	VP3.	In	the	literature,	it	has	been	hypothesized	that	acid	sensitivity	
is	 associated	with	 the	uptake	of	 FMDV	virions	 in	endosomes,	where	 the	pH	 is	 very	 low,	 thus	
triggering	viral	uncoating	and	genome	release.	Therefore,	although	acid	sensitivity	is	detrimental	
to	capsid	stability,	the	process	allows	for	the	release	of	viral	RNA	into	the	host	cell	in	order	to	





The	 propensity	 of	 the	 capsids	 to	 dissociate	 into	 pentamers	 at	 low	 pH	 and	 at	 moderate	
temperatures,	is	relevant	to	this	study.		It	is	possible	that	the	generation	of	more	stable	FMDV	
VLPs	could	result	in	a	higher	yield.		Work	carried	out	by	researchers	has	shown	that	site-directed	











et	 al.	 (2014)	 further	 showed	 how	 the	 double	 mutant	 VP1	 N17D/VP4	 S73N	 could	 also	 be	 a	
potential	acid	resistant	mutant.		The	FMDV	capsid	has	a	cluster	of	Histidine	(His)	residues	with	a	





it	 is	 important	 to	 target	 these	His-covalent	mediated	 interactions	between	pentamers	and	 to	
replace	the	His	with	other	amino	acid	residues	such	as	cysteine	as	shown	by	Porta	et	al.	(2013a)	
and	Kotecha	et	al.	(2015).		They	engineered	a	mutation	in	VP2	resulting	in	the	mutant	VP2	H93C,	


























number	 of	 FMDV	 VLPs	 assembled	 in	 the	 transient	 plant	 expression	 system,	 as	 the	 previous	
studies	focused	on	the	use	of	insect	cells	as	expression	platform.	Both	the	mutants	and	the	wild-
type	oP1-2A	were	expressed	in	the	absence	of	the	3C-protease,	compared	if	expression	of	the	



















encoding	 for	 the	 acid	 resistant	 mutants	 VP1	 N17D	 and	 VP1	 N17D/VP4	 S73N,	 acid	 and	 heat	














































































































developed	 at	 175	000	xg	 (SW	55Ti,	 35	min,	 12oC).	One	ml	 fractions	were	 collected	 from	 the	
bottom	of	the	tubes.	Five	hundred	microliters	of	each	fraction	was	precipitated	with	an	equal	

























Mutants	VP2	H93C,	VP1	N17D/VP4	S73N	and	VP3	A118V	were	made	 in	a	 similar	way	 to	VP1	
















Recombinant	 constructs	 confirmed	 by	 sequencing	 were	 used	 for	 transformation	 into	
Agrobacterium	AGL-I.	Positive	clones	were	identified	by	colony	PCR	(data	not	shown).			
3.3.2.	Transient	expression	of	derived	mutant	capsid	proteins	in	planta		
















such	 cleavage	 of	 VP0,	 upon	 encapsidation	 of	 RNA	 by	 the	 virion.	 Similarly,	 in	 this	 study,	 this	





















































































































103.7	 to	123.9	 (Figure	3.8A),	61.116	to	121.949	 (Figure	3.8B),	114.46	to	126.24	 (Figure	3.8C),	
118.53	to	123.24	(Figure	3.8D),	and	118.6	to	123.7	(Figure	3.8E)	respectively.	Graphs	representing	
VP1	N17D	(Figure	3.8A),	VP2	H93C	(Figure	3.8B)	and	VP1	N17D/VP4	S73N	(Figure	3.8C)	depict	the	
relationship	between	the	decrease	 in	 the	absorbance	recorded	at	260	nm	to	 that	at	280	nm.	
Although	the	absorbance	recorded	at	A260	could	potentially	relate	to	free	nucleic	acids	lying	in	
the	 purified	 samples,	 the	 fact	 that	 capsid	 formation	 was	 relying	 on	 the	 encapsidation	 of	
heterogeneous	nucleic	acids	should	not	be	disregarded.	The	RNA	levels	remained	constant	from	

































proteins	 were	 barely	 detected	 in	 the	 fractions	 after	 treatment	 at	 pH	 6.2,	 but	 however,	 the	
strongest	signal	was	seen	from	fraction	1	after	treatment	at	56oC	and	in	fraction	3	after	pH	5.2	






















detected	 by	 EM	 analysis	 (Figure	 3.10C).	 Interestingly,	 fractions	 representing	 oP1-2A	 (Figures	
3.10D	and	3.10E)	after	the	pH	assays	showed	the	presence	of	regularly	shaped	VLPs	(red	arrows).	
It	was	also	observed	 that	 fewer	VLPs	were	present	 in	 the	 sample	of	oP1-2A,	 treated	at	56oC	
(Figure	3.10F),	along	with	other	host	proteins.	The	VLP	count	after	treatment	of	oP1-2A	at	56oC,	










































































































Vaccines	 composed	of	 empty	 capsids	 that	 can	withstand	higher	 temperatures	would	be	 very	
advantageous	 especially	 for	 use	 in	 endemic	 regions	 where	 socioeconomic	 factors	 impede	
adequate	cold	chain	distribution.	Thus,	though	the	yields	of	VLPs	were	low	for	both	the	mutant	












two	 states.	 Consequently,	 this	 gives	 a	 reduced	 rate	 of	 irreversible	 dissociation	 at	 a	 certain	
temperature.		Furthermore,	it	can	be	formulated	that	in	the	absence	of	the	expression	of	the	3C-
protease	and	its	cleavage	properties,	oP1-2A	could	have	not	only	relied	on	the	cleavage	of	plant	
proteases	 as	 stipulated	 in	 Chapter	 2	 (Veerapen	 et	 al.,	 2017,	 manuscript	 submitted	 for	
publication),	and	thus	there	might	have	been	some	random	cleavages	on	the	capsid-precursor	
oP1-2A,	 conforming	 to	 formation	 of	 stable	 covalent	 bonds	 between	 pentamers	 which	 are	
behaving	 in	 a	 similar	 way	 as	 would	 acid-to-neutral	 mutants.	 Taken	 altogether,	 the	 capsid	
originating	from	oP1-2A	has	been	kinetically	stabilized	(Figure	3.12,	represented	by	the	greater	




















In	conclusion,	as	 it	 is	known	that	FMDV	 is	acid	and	heat	 labile,	 it	was	 imperative	 to	engineer	
mutations	which	would	help	promote	stability	and	formation	of	VLPs.	However,	it	was	shown	in	
this	study	that	the	non-mutated	oP1-2A	is	giving	rise	to	empty	capsids	that	that	can	tolerate	heat	
and	 relatively	 extreme	 acidic	 conditions,	 better	 than	 the	 mutants	 generated,	 which	 further	
represents	a	potential	candidate	vaccine	which	would	promote	shelf-life.	However,	the	attempt	




























Plant-based	 and	 subunit	 vaccines	 are	 considered	 to	 be	 easier	 to	 handle	 than	 conventional	
equivalents	as	their	preparation	circumvents	the	high	biocontainment	issues	required	for	many	
cell-based	 vaccines,	 and	 especially	 those	made	 from	virulent	 live	 viruses	 (Laere	 et	 al.,	 2016).	
Moreover,	plants	as	bioreactors	are	ideal	for	the	manufacture	of	high-demand	vaccines	based	on	
the	economy	of	scale	offered	by	agricultural	production	(Merlin	et	al.,	2014;	Rybicki,	2014).	In	
this	 part	 of	 my	 study,	 the	 number	 of	 plants	 used	 for	 expression	 was	 scaled	 up	 to	 produce	
sufficient	FMDV	empty	capsids	to	determine	their	immunogenicity	in	mice.		































































































96-well	 Maxisorp®	 microtitre	 plates	 (Nunc)	 were	 coated	 in	 triplicate	 with	 two-fold	 doubling	
dilutions	 (made	 in	 10	mM	 Tris,	 pH	 8.5)	 of	 the	 E.	 coli-produced	 P1-2A	 standard	 starting	 at	 a	




















Specified-Pathogen	 Free	Unit	 (UCT	 RAF	 SPF	Unit,	 Cape	 Town,	 South	 Africa)	were	 kept	 under	
Biosafety	 Level	 2	 (BSL-2)	 conditions	 in	 the	 Animal	 Unit	 at	 the	 Health	 Science	 Faculty,	 UCT.	
Approval	for	this	study	was	granted	by	the	Animal	Research	Ethics	Committee	at	UCT	(AEC	No.	
016-026).	
Female	mice	 (8	 to	 10	 weeks	 old)	 were	 immunized	 with	 the	 vaccine	 candidates	 prepared	 as	
described	 in	 section	 4.2.1,	Method	 B.	N.	 benthamiana	 leaves	 infiltrated	with	 pEAQ-HT	 were	










P1-2A	VLPs	 2	 n/a	 5	














To	 evaluate	 the	 anti-P1-2A	 immune	 response	 elicited	 by	 each	 mouse,	 the	 prebleed,	 bleed	
collected	at	41	dpv	and	final	bleed	sera	were	diluted	1:50	in	TBS	blocking	buffer	and	incubated	







vaccinated	 with	 plant-purified	 pEAQ-HT	 served	 as	 a	 negative	 control.	 Positive	 control	 wells	
contained	 rabbit-raised	anti-P1-2A	 to	validate	 the	ELISA.	Negative	ELISA	controls	 consisted	of	
wells	containing	antigen,	and	incubation	with	secondary	antibody	only.	




















ELISA	 requires	 the	 detection	 of	 the	 antigen	 of	 interest	 in	 its	 non-denatured	 form.	 To	 assess	
whether	 the	 rabbit-raised	 anti-P1-2A	 could	 be	 used	 as	 primary	 antibody	 in	 ELISAs	 to	 detect	
conformationally	 specific	 epitopes,	 a	 dot-blot	was	 performed	 using	 both	 non-denatured	 and	
denatured	purified	P1-2A	capsid	proteins	(Figure	4.1B).	The	signal	detected	for	both	the	plant-
produced	 and	E.	 coli-produced	oP1-2A	was	 stronger	 in	 the	 non-denatured	 forms	 than	 in	 the	
denatured	 forms,	 suggesting	 that	 the	 rabbit-raised	anti-P1-2A	would	serve	as	a	good	primary	
antibody.		
Western	blotting	(Figure	4.1C(i))	showed	that	fractions	4	to	14	were	positive	for	the	presence	of	
capsid	 proteins	 with	 the	 detection	 of	 VP0,	 VP1	 and	 VP3	 as	 indicated	 with	 the	 red	 arrows.		





An	 I-ELISA	using	 rabbit-raised	 anti-P1-2A	 as	 primary	 antibody	was	 performed	 to	 quantify	 the	
fractions	containing	the	putative	VLPs.	ELISAs	performed	on	selected	fractions	10	to	14	showed	
a	range	of	concentrations	from	197	ng/ml	to	170	ng/ml,	which	represents	a	yield	of	~0.0030	µg	













VLPs	were	 pelleted	 through	OptiprepTM	 cushions,	 resuspended	 in	 1x	 NTE	 buffer,	 pH	 8.0	 and	
resuspended	 samples	 pooled	 (Figure	 4.2).	 Samples	 were	 subjected	 to	 maturation	 at	 room	























































































































































Figure	 4.6:	Western	 blot	 analysis	 of	 pooled	mice	 antisera	 from	 the	 three	 groups:	 P1-2A	 VLPs,	 P1-2A	 VLPs	 and	















However,	 the	 amount	 of	 purified	 FMDV	 VLPs	 produced	 from	 ultracentrifugation	 through	 a	
continuous	OptiprepTM	gradient	was	low,	despite	scaling	up	the	amount	of	biomass	processed.		
In	 the	past,	many	studies	using	plants	as	an	expression	platform	for	 the	production	of	FMDV	
vaccine	 candidates	 tested	 the	 administration	 of	 crude	 plant	 extracts	 in	 animals	 as	 vaccine	











sedimenting	 the	 VLPs	 using	 a	 30%	OptiprepTM	 cushion,	 after	 which	 the	 pellets	 were	 pooled,	
resuspended	 in	 1x	 NTE	 buffer	 (pH	 8.0)	 and	matured	 at	 room	 temperature.	 The	 sample	 was	
further	clarified	by	centrifugation	(JA-14,	30	021	xg,	15	min,	4oC)	and	the	highly	soluble	FMDV	









The	 plant-expressed	 VLPs,	 when	 administered	 both	 with	 and	 without	 adjuvant,	 stimulated	
humoral	responses	in	the	mice	as	determined	by	I-ELISA.	There	was	a	very	slight	increase	in	P1-
2A-specific	antibodies	detected	41	dpv	but	this	response	was	escalated	at	58	dpv,	after	a	boost	








being	 available.	 Considering	 the	 number	 of	 animals	which	 require	 FMD	 vaccination,	 vaccines	
formulated	with	Montanide	 could	 provide	 effective	 immunization	with	 fewer	 and	potentially	
























































has	 a	 viral	 reservoir	 of	 the	 SAT	 serotypes	 in	 the	 African	 buffalo	 population	 from	 the	 Kruger	
National	Park	(KNP),	although	they	are	asymptomatic.	Consequently,	protective	measures	have	
been	taken	to	monitor	for	infections	and	prevent	potential	outbreaks	by	vaccination.	Animals	in	
the	buffer	 zone	next	 to	 the	KNP	are	 vaccinated	 yearly.	 The	 vaccines	 available	on	 the	market	




candidate	 in	 the	 form	 of	 virus-like-particles	 (VLPs),	 also	 known	 as	 empty	 capsids.	 	 VLPs	 are	
multiprotein	structures	that	mimic	the	organization	and	conformation	of	the	authentic	native	
virus	particle,	but	lack	the	viral	genome.	Thus,	such	a	vaccine	would	be	a	potentially		safer	and	



























proteins’	production	 to	occur	at	5	days	post	 infiltration	 (dpi)	using	an	A.	 tumefaciens	 culture	




achieving	 better	 expression	 and	 a	 higher	 amount	 of	 VLPs,	 excluding	 expression	 of	 the	 3C-
protease,	would	be	to	co-infiltrate	the	VPs	0,	1	and	3	in	N.	benthamiana	 leaves,	while	varying	









studies,	 the	acid	 resistant	mutants	VP1	N17D	 (Caridi	et	al.,	 2015;	 Liang	et	al.,	 2014)	and	VP1	
N17D/VP4	S73N	(Liang	et	al.,	2014),	and	heat	and	acid	resistant	mutant	VP2	H93C	(Porta	et	al.,	


















supernatant	was	 used	 for	 inoculations	 in	mice.	 This	method	was	 preferred	 compared	 to	 the	
‘complete’	purification	through	a	continuous	gradient,	as	extremely	 low	yields	obtained	were	
considered	 inadequate	 for	 stimulating	 a	 measurable	 immune	 response.	 However,	 other	
purification	 methods	 such	 as	 size	 exclusion	 chromatography,	 which	 Lin	 et	 al.	 (2015)	 used	
successfully	to	purify	Enterovirus	71	VLPs,	could	be	a	good	alternative	to	ultracentrifugation.	A	
second	 method	 would	 be	 purification	 via	 precipitation	 with	 polyethylene	 glycol,	 and	 anion	








animals	 were	 first	 collected	 and	 analysed	 for	 the	 antibody	 baseline	 level.	 The	 animals	 were	

























increase	 expression	 and	 production	 of	 the	 VLPs,	 the	 inclusion	 of	 a	maturation	 step	 at	 room	
temperature	 would	 improve	 the	 stability	 and	 shape	 of	 the	 particles.	 The	 native	 P1-2A	 VLPs	
compared	 to	 its	mutants,	 demonstrated	 better	 expression	 and	 resistance	when	 subjected	 to	
certain	extreme	conditions.	Finally,	I	showed	that	these	VLPs	when	formulated	with	or	without	
the	Montanide	 ISA	50	adjuvant	elicited	a	 significant	humoral	 response	 in	mice.	 These	 results	

















































Target	genes	 Expression	system		 Vaccine	delivery	system	 Animal	model	 References	




P1-2A,	3C,	L-protease	 Insect	cells	 AcMNPV n/a	 Roosien	et	al.	(1990)	
P1-2A,	3C	 Insect	cells	 pOPINE and AcMNPV n/a	 Porta	et	al.	(2013b)	
P1-2A,	3C	 Silkworm	 Baculovirus	Bm	 Cattle	 Li	et	al.	(2008)	
VP1,	VP2,	VP3,	VP4	 Insect	cells	 Bacmids	 Guinea	pig	 Liu	et	al.	(2017)	




Target	genes	 Expression	system		 Vaccine	delivery	system	 Animal	model	 References	
VP1	 Crotalaria	juncea	 pCAMBIA	vector	 Guinea	pig	 Rao	et	al.	(2012)	
VP1	 Arabidopsis	thaliana	 pROK1	 Mice	 Carrillo	et	al.	(1998)	
P1-3C	 Alfalfa	 pROK	 Mice	 Dus	Santos	et	al.	(2005)	




Target	genes	 Expression	system		 Vaccine	delivery	system	 Animal	model	 References	




VP1,	VP4,	2D,	3D	 N.	benthamiana	 Phytovirus	 Mice	 Andrianova	et	al.	(2011)	
		 		 This	study	 		 		
Target	genes	 Expression	system		 Vaccine	delivery	system	 Animal	model	 References	
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